Pharmafile Logo
Pharmafocus logo
Advanced Search

Plant-based COVID-19 vaccine approved

February 25, 2022
Medical Communications

Medicago and GlaxoSmithKline (GSK) have announced the approval by Health Canada of COVIFENZ®, a COVID-19 vaccine manufactured in plants, with …

News

South Korea approves Pfizer vaccine for children aged 5-11

February 24, 2022
Business Services

South Korea’s drug safety agency on authorised the use of Pfizer’s COVID-19 vaccine on 23 February, for children aged between …

News

CDC: some should wait longer for second COVID-19 vaccination

February 24, 2022
Business Services

The CDC updated its vaccine guidance for COVID-19, recommending that some American over the age of 12 who have received …

News

New sickle cell treatment administered to first patients in England

February 24, 2022
Business Services

Sickle cell patients have now begun receiving the first new treatment for the blood disorder in over 20 years. The …

News

NICE recommends GSK’s ZEJULA (niraparib) for ovarian cancer patients

February 24, 2022
Business Services

NICE has issued a Final Appraisal Determination (FAD), recommending the use of ZEJULA (niraparib) on the NHS. Niraparib is recommended …

News

93% accuracy in new Alzheimer’s test, according to international study

February 23, 2022
Research and Development

The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …

News

Extra blood test could help detect risk of death from heart attack

February 23, 2022
Research and Development

Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …

News

FDA places gene therapy trial on hold

February 23, 2022
Research and Development

Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …

News

NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types

February 23, 2022
Research and Development

NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …

News

FDA grants approval for expanded indication of heart failure sensor

February 22, 2022
Manufacturing and Production

The FDA has granted approval for an expanded indication of Abbott’s CardioMEMS HF System, a small implantable sensor that can …

News

NovoBiome and Inserm begin collaboration into human intestinal physiology

February 22, 2022
Manufacturing and Production

NovoBiome, a drug discovery company developing breakthrough Live Biotherapeutics Products, announced that it has signed a new collaboration with the …

News

UK to offer extra COVID-19 booster for over-75s and high risk in spring

February 22, 2022
Manufacturing and Production

An additional booster dose will be offered to all adults over-75, as well as the most vulnerable over-12s, in the …

News

Apollo Therapeutics and King’s College London collaborate for translational biology and drug development

February 22, 2022
Manufacturing and Production

Apollo Therapeutics has expanded its partnerships with world-leading UK research institutions, entering into a strategic collaboration with King’s College, London. …

News

CanSinoBIO’s Convidecia approved as heterologous COVID-19 booster in China

February 21, 2022
Sales and Marketing

CanSino Biologics announced that its recombinant novel coronavirus vaccine has been approved by the Joint Prevention and Control Mechanism of …

News

FDA approval of first disease-modifying drug for treatment of rare lifelong anaemia

February 21, 2022
Sales and Marketing

Agios Pharmaceuticals has announced the FDA approval of Pyrukynd (mitapivat), for the treatment of haemolytic anaemia in adults with pyruvate …

News

‘Historic’ results for breast cancer drug and promise for broader use

February 21, 2022
Sales and Marketing

AstraZeneca has shared that its drug, Enhertu, has demonstrated meaningful survival improvements in patients with breast cancer, compared with physician’s …

News

FDA considers approving second COVID-19 booster jab

February 21, 2022
Sales and Marketing

US health regulators are looking at authorising a potential fourth dose of a COVID-19 vaccine, as reported by the Wall …

News

Study shows antibiotics affect gut microbes of newborns

February 18, 2022
Medical Communications

Researchers from the Universities of Edinburgh and Birmingham, with the Spaarne Hospital and University Medical Centre Utrecht, Netherlands, have conducted …

News

Pfizer and BioNTech Omicron vaccine delayed

February 18, 2022
Medical Communications

The delivery of Pfizer and BioNTech SE’s vaccine, targeted specifically towards the Omicron COVID-19 variant has been delayed by several …

News

NHS bosses call for free COVID-19 tests and isolation to remain

February 18, 2022
Medical Communications

NHS bosses have called for free COVID-19 testing to remain, in spite of speculation that this could be scrapped. Boris …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025